The Relationship of Nausea and Vomiting during Pregnancy with Pregnancy Complications

Document Type: Original Research Article

Authors

1 Graduted in Counseling in Midwifery, Student Research Committee, School of Nursing and Midwifery, Shahroud University of Medical Sciences, Shahroud, Iran

2 Graduted in Epidemiology, Shahroud University of Medical Sciences, Shahroud, Iran

3 MSc Student in Epidemiology, Student Research Committee, Department of Epidemiology, Faculty of Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran

4 Assistant Professor, Department of Midwifery, School of Nursing and Midwifery, Shahroud University of Medical Sciences, Shahroud, Iran

Abstract

Background & aim: Nausea and vomiting are among the most common complaints during pregnancy observed in patients with severe pregnancy outcomes. The purpose of this study was to investigate the relationship of nausea and vomiting during pregnancy (NVP) with some pregnancy complications.
Methods: This cross-sectional study was conducted on 778 mothers within the age range of 18-35 years who werew experiencing their first to third pregnancy and had single fetuses born from April to September 2017 in Shahroud Teaching Hospital, Shahroud, Iran. The study population was selected using the census method. The data were collected using a questionnaire included demographic characteristics as well as pregnancy complications. A visual analogue scale (VAS) was also used to assess nausea and vomiting. The data were analyzed in SPSS software (version 18) using the Chi-square test and Spearman correlation coefficient.
Results: In this study, 72.75% of the mothers reported to have some degrees of nausea and vomiting. In this regard, based on the VAS, the mean score of NVP was obtained as 4.29±3.41. As the results indicated, NVP had a significant relationship with preterm labor (P=0.002), hypertension (P=0.003), anemia (P=0.002), and cesarean section (P=0.009). However, there was no association between nausea and vomiting with the medical illnesses during pregnancy, gestational diabetes, hypothyroidism, (P=0.12), and bleeding/ spotting.
Conclusion: According to the results, NVP was associated with pregnancy complications including preterm delivery, hypertension, anemia, and cesarean section.

Keywords


Introduction


     During a normal pregnancy, almost all body organs undergo anatomical and functional changes. These changes are the cause of many pregnancy discomforts and disorders. Nausea and vomiting during pregnancy (NVP) is an unpleasant condition that is also called morning sickness. Approximately 90-95% of the women experience varying degrees of NVP (1). This disorder usually starts from the second to the fifth week of pregnancy and ends after 14-20 weeks of pregnancy. According to the literature, the frequency of NVP is 69.7% in Iran (2, 3). This problem is seen in early pregnancy in about 80% of the women and continues until the end of the pregnancy in 20% of the ​​cases (4, 5).

     Hyperemesis gravidarum is a severe form of NVP that is seen in 0.3-3% of pregnancies (6). In this case, vomiting is so severe that it leads to weight loss, dehydration, ketosis, alkalosis (due to hydrochloric acid excretion), hypokalemia, acidosis, and transient liver dysfunction. This condition is highly different from and more severe than the usual nausea and morning vomiting in pregnant women (4). It is caused by the increased levels of human chorionic gonadotropin, estrogen, progesterone, leptin, placental growth hormone, prolactin, thyroxine, and adrenocorticotropic, ghrelin, nesfatin, and PYY-3.

     The occurrence of this type of nausea and vomiting is also affected by race, family, previous history, and psychological, metabolic, and toxic factors. Other causes of hyperemesis gravidarum may include twin or multiple pregnancies, some fetal anomalies (e.g., trisomy 21 and hydrops fetalis), and trophoblastic diseases producing high levels of placental gonadotropin hormone. Pregnant women with such a condition should be usually hospitalized for hydration and electrolyte balance (7-9).

     Treatment of NVP, depending on the severity of symptoms, can include a change in the lifestyle, hydration, and medication regimens. In the more severe cases, hospitalization, intravenous hydration, intravenous medications, or even complete intravenous nutrition may be required (10). A review of the evidence-based care of NVP suggests that this condition affects maternal health and quality of life during pregnancy. It also imposes financial burdens on the mothers and the society (10, 11). The NVP can cause discomfort in the pregnant mother and her family and lead to disabilities in performing maternal duties and reduction of daily functioning (9, 10, 12). Although NVP is prevalent in pregnant women, few studies have been conducted to investigate the relationship between this variable and pregnancy complications (9).

     Several studies have reported a relationship between NVP and a reduced risk of miscarriage (10, 13). According to these studies, this condition leads to the improvement of maternal nutrition and social and occupational support. Hence, NVP can have a protective effect on the fetus (14). However, some studies suggest that NVP can result in preterm labor and low birth weight (10, 14-16)

     There are contradictory results on the association of NVP with pregnancy complications, such as preeclampsia, diabetes, hypertension, and proteinuria. Moreover, some reports have rejected the role of nausea and vomiting in preterm labor and fetal weight (10, 12, 15-18). The high importance of this subject and presence of different reports on NVP complications, in addition to the lack of such studies in Shahroud, especially in the birth center of this city, underscore the need for performing a study addressing this domain. Regarding this, the present study was conducted to evaluate the relationship of NVP with some pregnancy complications.

Materials and Methods

This cross-sectional study was conducted on all pregnant mothers who referred to Shahroud Bahar Hospital in Shahroud, Iran, from April to the end of September of 2016. A total of 1,014 cases were subjected to sampling using the census method. The inclusion criteria were: 1) age of 18-35 years, 2) first to third pregnancy, and 3) singleton pregnancy. On the other hand, the exclusion criteria included: 1) multiple pregnancy, 2) experience of hyperemesis gravidarum during pregnancy due to the increased risk of pregnancy and labor, 3) no history of high blood pressure (i.e., a blood pressure of 140/90), and 4) unwillingness to cooperate with the researcher to complete the questionnaire (which was based on the patient's own statements).

Finally, 778 people participated in the study. The data collection tool included a researcher-made checklist designed based on the objective of the study. It consisted of three sections related to demographic data (including age, occupation, level of education, place of residence, and drug addiction), pregnancy complications (including personal history or any medical illness before or during pregnancy [e.g., diabetes, hypertension, hypothyroidism, anemia, bleeding, and spotting], and date and type of labor), and visual analogue scale, assessing maternal nausea and vomiting. The pregnant mothers were asked about NVP when they were admitted to the hospital for delivery until discharge. Information was collected based on the arrival of pregnant mothers and no specific timing was considered.

To assess the degree of nausea and vomiting in early pregnancy, all mothers were trained to score the severity of nausea and vomiting on a visual analogue scale (VAS). This tool is a 10-cm ruler (range between 0 and 10), in which the zero score represents the lack of nausea and vomiting, while scores of 1-3, 4-6, 7-9, and 10 signify mild, moderate, severe, and very severe nausea and vomiting, respectively. The calculation of reliability was not required for the first two parts of the checklist. However, the reliability of the third part was confirmed in a previous study (19). The demographic information was collected based on the measurement scale to determine the extent of NVP and some of the postpartum and pre-delivery complications.

The patients were monitored from the moment of admission up to childbirth. The validity and reliability of the tool measuring nausea and vomiting have been confirmed in several studies (20, 21). After coding the collected data, they were analyzed in SPSS software (version 18). Frequency distribution, mean, and standard deviation were used to describe the data. In addition, the relationship between pregnancy complications and NVP was investigated using the one way ANOVA, Chi-square test (or Fisher's exact test), and Spearman correlation coefficient at a p-value of <0.05.

Results

     Out of the 1,014 pregnant mothers, 778 cases met the inclusion criteria (i.e., age of 18-35 years, first to third pregnancy, and singleton pregnancy) and were included in the study. The majority of the mothers were housewives and were living in the city without any drug addiction (Table 1).

The mean age of the mothers was 27.46±4.37 years. With regard to the level of education, 432 (42.6 %) mothers had a diploma.

  Among all mothers, 212 (27.24%) cases had no symptoms of NVP in the first trimester. However, 113 (14.52%), 218 (28.02%), 173 (22.23%), and 60 (7.99%) cases had mild, moderate, severe, and very severe NVP, respectively (Table 2).

The overall mean score of NVP was obtained as 4.29±3.41. The results also revealed the probable role of NVP in increasing the chance of anemia and hypertension.

     In general, 302 (38%) women had normal vaginal labor, while 626 (47%) cases had cesarean sections. Out of 778 mothers, 73 (9.3%) subjects had preterm delivery, and others had term birth. The NVP was found to directly associate with the chance of cesarean delivery (P=0.009) and preterm delivery (P=0.023). However, this variable was not correlated with neonatal Apgar score (Table 3).

Discussion

     The results of this study revealed that 72.75% of the women had varying degrees of NVP, and the rest of them did not show any symptoms. Based on the VAS, the mean score of NVP in mothers was 4.29±3.41, which is inconsistent with the results of the research conducted by Shafati et al. (11) and Timing et al. (10). This high rate, compared to those reported in similar studies, maybe due to the low tolerance of mothers to nausea and lack of appropriate planning to prevent NVP. This underscores the need for the provision of training on lifestyle changes and the cares required to prevent vomiting.

     In the present study, there was a positive and significant relationship between NVP and preterm birth, which is in line with the results of the studies performed by Yazdani et al. (20), Timing et al. (10), Jenabi et al. (22), and McParlin et al. (15). However, inconsistent with our results, Mate Sida et al. (23) and Patil et al. found no association between NVP and an increased risk of preterm labor (24). It seems that the reason for the association between NVP and lower risk of preterm delivery is the implementation of an appropriate treatment to reduce the complications of NVP and increase social and family support in these women.

     The results of the present study also revealed a positive and significant relationship between NVP score and hypertension. In this regard, the rate of hypertension increased with the elevation of NVP score. This result is inconsistent with those of a study conducted by Yazdani et al. (20) but consistent with the results of the studies performed by Chortatos et al. (14), Mennella et al. (25), and Vikanes et al. (17). This may be due to the lack of proper training and planning to deal with vomiting and nausea

     A direct and significant relationship was also found between NVP and cesarean section. This result is in disagreement with those obtained by Timing et al. (10), Chortatos et al. (14), Dodoes et al. (26), and Yazdani et al. This discrepancy may be due to the maternal inability to perform normal vaginal delivery, which eventually leads to cesarean delivery to receive appropriate support. However, different reasons account for cesarean delivery. Therefore, NVP is just one of the influencing factors in this regard as reported in different studies (27-29).

     The 5-minute Apgar score of the mothers with a history of NVP was less than 7, which is inconsistent with the values reported by Yazdani et al. (20) and Green et al. (30). This discrepancy might be due to the conditions of research setting that requires proper planning to deal with such effects. The results also revealed a significant relationship between NVP and anemia, which is in disagreement with the findings obtained by similar research (20). This difference might be due to the appropriate treatment of this disease during pregnancy.

     One of the limitations of this study was its retrospective design using a single hospital setting. Furthermore, the present study was targeted toward the evaluation of a few complications as more complications were likely to occur. However, the strength of this study was the examination of the difference in the degree of NVP, whereas most of the previous studies focused on the presence of nausea and vomiting and the failure to determine the cause of preterm birth.

     Further prospective, large-population studies are recommended to be conducted considering contradictory information regarding the association of NVP with adverse pregnancy outcomes. It is also suggested to perform studies with the aim of training mothers who experience nausea and vomiting in early pregnancy and addressing some of the complications of pregnancy and ways to reduce them.

Conclusion

     The results of the present study revealed a direct relationship between NVP and cesarean delivery, preterm delivery, 5-min Apgar scoreof < 7, anemia, and high blood pressure.

Acknowledgements

     The present study was derived from a research project approved under the Code of 9678 by Shahroud University of Medical Sciences and the Ethics Code of IR.SHMU.REC.1394.104 by the Research Deputy of Shahroud University of Medical Sciences.

     We appreciate the Research Deputy of Shahroud University of Medical Sciences for their financial support, all mothers participated in the study, the staff of Bahar Hospital, and all those who helped us in performing this project.

Conflicts of interest

Authors declared no conflicts of interest.

  1. Borrelli F, Capasso R, Aviello G, Pittler MH, Izzo AA. Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting. Obstetrics & Gynecology. 2005; 105(4):849-856.
  2. Hosseinkhani SN, Garshsbi A. The effect of ginger on pregnancy vomiting: a double blind randomized clinical trial. Daneshvar. 2012; 20(101):35-42.
  3. Eftekhari N. A comparison of ondansetron and promethasin in treating hyperemesis gravidarum. Journal of Kerman University of Medical Sciences. 2013; 20(4):354-365.
  4. Lacasse A, Rey E, Ferreira E, Morin C, Bérard A. Epidemiology of nausea and vomiting of pregnancy: prevalence, severity, determinants, and the importance of race/ethnicity. BMC Pregnancy and Childbirth. 2009; 9(1):26.
  5. Cunningham F, Leveno K, Bloom S, Spong CY, Dashe J. Williams obstetrics. 20th ed. New York: McGraw-Hill; 2007. P. 706-710.
  6. Sabet B, Salkhordeh H, Hedayati Khalil M, Mahboobi M, Babajani S. A review of the ginger products use in reducing pregnancy nausea and vomiting. Paramedical Sciences and Military Health. 2017; 11(4):50-56.
  7. McCarthy FP, Lutomski JE, Greene RA. Hyperemesis gravidarum: current perspectives. International Journal of Women's Health. 2014; 6:719.
  8. Vikanes ÅV, Støer NC, Magnus P, Grjibovski AM. Hyperemesis gravidarum and pregnancy outcomes in the Norwegian mother and child cohort–a cohort study. BMC Pregnancy and Childbirth. 2013; 13(1):169.
  9. Abedian Z, Abbaszadeh N, Latifnejad Roudsari R, Shakeri MT. The effect of telephone support on the severity of nausea and vomiting in the first trimester of pregnancy in the primiparous women. The Iranian Journal of Obstetrics, Gynecology and Infertility. 2014; 17(118):18-29.
  10. Temming L, Franco A, Istwan N, Rhea D, Desch C, Stanziano G, et al. Adverse pregnancy outcomes in women with nausea and vomiting of pregnancy. The Journal of Maternal-Fetal & Neonatal Medicine. 2014; 27(1):84-88.
  11. Shafti V, Zakerihamidi M. Relationship between nausea and pregnancy vomiting and fetus gender. Journal of Neshabur University of Medical Sciences. 2017; 5(1):66-72.
  12. Lamyian M. Quality of life in women with nausea and vomiting from pregnancy. Caspian Journal of Reproductive Medicine. 2015; 1(3):17-20.
  13. Virus Z, Patient RY, Join O, Expert AA. Nausea and vomiting of pregnancy (NVP). New York: MotherToBaby; 2015.
  14. Chortatos A, Haugen M, Iversen PO, Vikanes Å, Eberhard-Gran M, Bjelland EK, et al. Pregnancy complications and birth outcomes among women experiencing nausea only or nausea and vomiting during pregnancy in the Norwegian Mother and Child Cohort Study. BMC Pregnancy and Childbirth. 2015; 15(1):138.
  15. McParlin C, Graham R, Robson S. Caring for women with nausea and vomiting in pregnancy: new approaches. British Journal of Midwifery. 2008; 16(5):280-285.
  16. Ferreira E, Bussières JF, Turcotte V, Duperron L, Ouellet G. Case–control study comparing droperidol plus diphenhydramine with conventional treatment in hyperemesis gravidarum. Journal of Pharmacy Technology. 2003; 19(6):349-354.
  17. Vikanes Å, Skjærven R, Grjibovski AM, Gunnes N, Vangen S, Magnus P. Recurrence of hyperemesis gravidarum across generations: population based cohort study. BMJ. 2010; 340:c2050.
  18. Smith C, Crowther C, Beilby J, Dandeaux J. The impact of nausea and vomiting on women: a burden of early pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2000; 40(4):397-401.
  19. Montazeri AS, Raei M, Hamidzadeh A, Hamzekhani M, Soozani A, Kalatejari M, et al. Effect of ginger on postoperative nausea and vomiting. Knowledge and Health. 2012; 7(3):118-123.
  20. Yazdani S, Sadat Z. Evaluating complications of pregnancy in patients with hyperemesis gravidarum. Feyz. 2011; 14(4):426-430.
  21. Firouzbakht M, Nikpour M, Omidvar S, Kiapour A. Comparative study of effects of ginger with vit. B6 in treatment nausea and vomiting during pregnancy. Family Health. 2013; 1(3):8-13.
  22. Jenabi E. The correlation of pregnancy complication and Body Mass Index. Procedia-Social and Behavioral Sciences. 2011; 28:563-567.
  23. Mitsuda N, Eitoku M, Yamasaki K, Sakaguchi M, Yasumitsu-Lovell K, Maeda N, et al. Nausea and vomiting during pregnancy associated with lower incidence of preterm births: the Japan Environment and Children’s Study (JECS). BMC Pregnancy and Childbirth. 2018; 18(1):268.
  24. Patil CL, Abrams ET, Steinmetz AR, Young SL. Appetite sensations and nausea and vomiting in pregnancy: an overview of the explanations. Ecology of Food and Nutrition. 2012; 51(5):394-417.
  25. Mennella JA. Ontogeny of taste preferences: basic biology and implications for health. The American Journal of Clinical Nutrition. 2014; 99(3):704S-711S.
  26. Dodds L, Fell DB, Joseph KS, Allen VM, Butler B. Outcomes of pregnancies complicated by hyperemesis gravidarum. Obstetrics & Gynecology. 2006; 107(2):285-292.
  27. Nazari S, Tabatabayee CM, Bagheri M, Sharifnia H. Prevalence and some maternal and neonatal outcomes of vaginal delivery after cesarean and repeat cesarean in a hospital repeated Bentolhoda Bojnoord. Journal of North Khorasan University of Medical Sciences. 2016; 8(1):167-177. 
  28. Khayyatian N, Nasiri S. Prevalence of cesarean section and its causes in governmental obstetric hospitals of Kashan-2014. Journal of Health and Care. 2016; 18(1):28-36.
  29. Yaghoubi M, Javadi M, Karimi S, Pirasteh V. Costs of normal and caesarian section delivery before and after implementation of the national health sector evolution plan in Iran from the perspectives of patients, health service providers and hospitals. Journal of School of Public Health and Institute of Public Health Research. 2018; 16(2):114-125.
  30. Grooten IJ, Mol BW, van der Post JA, Ris-Stalpers C, Kok M, Bais JM, et al. Early nasogastric tube feeding in optimising treatment for hyperemesis gravidarum: the MOTHER randomised controlled trial (Maternal and Offspring outcomes after Treatment of HyperEmesis by Refeeding). BMC Pregnancy and Childbirth. 2016; 16(1):22.